Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. [electronic resource]
Producer: 20070515Description: 1777-81 p. digitalISSN:- 0022-5347
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Biomarkers, Tumor -- blood
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Docetaxel
- Drug Administration Schedule
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- blood
- Pilot Projects
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatectomy
- Prostatic Neoplasms -- drug therapy
- Radiation-Sensitizing Agents
- Risk Factors
- Survival Rate -- trends
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.